文献速递瓣膜病与结构性心脏病冠心病

二叶式主动脉瓣:长期患病率与死亡率

Bicuspid aortic valve: long-term morbidity and mortality.
PubMed 文献 · Eur Heart J · 2023-01-01

该回顾性队列纳入1980至2009年Olmsted县652例超声诊断的二叶式主动脉瓣患者,中位随访19.1年。终生累积患病负担达86%,典型瓣膜-主动脉病变者生存与人群相似,复杂病变者死亡风险增高。

要点

  • 二叶式主动脉瓣终生患病负担高,90岁时瓣膜-主动脉病变几乎不可避免。
  • 感染性心内膜炎终生发生率高于主动脉夹层。
  • 典型瓣膜-主动脉病变长期生存与人群相似,复杂病变死亡风险增高。

核心结论

  • 二叶式主动脉瓣终生患病负担高,至90岁时瓣膜-主动脉病变接近不可避免。
  • 感染性心内膜炎终生发生率高于主动脉夹层。
  • 典型瓣膜-主动脉病变长期生存与年龄性别匹配人群相似,复杂瓣膜-主动脉病变死亡风险增高。

研究设计与样本

  • 回顾性识别1980年1月1日至2009年12月31日Olmsted县居民中超声心动图诊断的二叶式主动脉瓣患者,共652例。
  • 中位(IQR)年龄37(22-53)岁,成人525例(81%),儿童127例(19%)。
  • 中位(IQR)随访19.1(12.9-25.8)年。
  • 分为典型瓣膜-主动脉病变562例(86%)和复杂瓣膜-主动脉病变90例(14%)。

主要发现

  • 从出生至90岁的总累积终生患病负担为86%(95%CI 82.5-89.7)。
  • 累积终生进展至≥中度主动脉瓣狭窄或反流为80.3%,主动脉瓣手术为68.5%,主动脉瘤≥45 mm或z-score≥3为75.4%,主动脉手术为27%,感染性心内膜炎为6%,主动脉夹层为1.6%。

临床怎么用

  • 对二叶式主动脉瓣患者应长期监测瓣膜功能及主动脉 dimension,关注终生高患病负担。
  • 区分典型与复杂瓣膜-主动脉病变,复杂病变者需更积极管理以应对超额死亡风险。
  • 感染性心内膜炎终生风险高于主动脉夹层,临床需警惕。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Bicuspid aortic valve (BAV) is the most common congenital heart anomaly. Lifetime morbidity and whether long-term survival varies according to BAV patient-sub-groups are unknown. This study aimed to assess lifetime morbidity and long-term survival in BAV patients in the community. METHODS: The authors retrospectively identified all Olmsted County (Minnesota) residents with an echocardiographic diagnosis of BAV from 1 January 1980 to 31 December 2009, including patients with typical valvulo-aortopathy (BAV without accelerated valvulo-aortopathy or associated disorders), and those with complex valvulo-aortopathy (BAV with accelerated valvulo-aortopathy or associated disorders). RESULTS: 652 consecutive diagnosed BAV patients [median (IQR) age 37 (22-53) years; 525 (81%) adult and 127 (19%) paediatric] were followed for a median (IQR) of 19.1 (12.9-25.8) years. The total cumulative lifetime morbidity burden (from birth to age 90) was 86% (95% CI 82.5-89.7); cumulative lifetime progression to ≥ moderate aortic stenosis or regurgitation, aortic valve surgery, aortic aneurysm ≥45 mm or z-score ≥3, aorta surgery, infective endocarditis and aortic dissection was 80.3%, 68.5%, 75.4%, 27%, 6% and 1.6%, respectively. Survival of patients with typical valvulo-aortopathy [562 (86%), age 40 (28-55) years, 86% adults] was similar to age-sex-matched Minnesota population (P = .12). Conversely, survival of patients with complex valvulo-aortopathy [90 (14%), age 14 (3-26) years, 57% paediatric] was lower than expected, with a relative excess mortality risk of 2.25 (95% CI 1.21-4.19) (P = .01). CONCLUSION: The BAV condition exhibits a high lifetime morbidity burden where valvulo-aortopathy is close to unavoidable by age 90. The lifetime incidence of infective endocarditis is higher than that of aortic dissection. The most common BAV clinical presentation is the typical valvulo-aortopathy with preserved expected long-term survival, while the complex valvulo-aortopathy presentation incurs higher mortality.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Yang LT, Ye Z, Wajih Ullah M, et al. Bicuspid aortic valve: long-term morbidity and mortality. Eur Heart J. 2023. PMID: 37611071. doi:10.1093/eurheartj/ehad477

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。